As globalization continues to reshape the pharmaceutical landscape, manufacturers are increasingly seeking to enhance their supply chain efficiencies. Outsourcing production to countries with lower operational costs, such as India and China, has become a common practice. This has not only reduced production costs but also allowed companies to focus on their core competencies, such as research and development and marketing. However, this trend also brings challenges, such as quality control and intellectual property protection.